Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Leishmaniasis Treatment market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for Leishmaniasis Treatment are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Leishmaniasis Treatment market segmented into
Meglumine Antimoniate
Pentamidine
Hydroxyl Amidine Stilbene
Amphotericin B
Based on the end-use, the global Leishmaniasis Treatment market classified into
Visceral Leishmaniasis
Cutaneous Leishmaniasis
Based on geography, the global Leishmaniasis Treatment market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Merck
iCo Therapeutics
AEterna Zentaris
AEterna Zentaris AG
Eurofins Advinus
Pieris Pharmaceuticals
Dafra Pharma
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL LEISHMANIASIS TREATMENT INDUSTRY
2.1 Summary about Leishmaniasis Treatment Industry
2.2 Leishmaniasis Treatment Market Trends
2.2.1 Leishmaniasis Treatment Production & Consumption Trends
2.2.2 Leishmaniasis Treatment Demand Structure Trends
2.3 Leishmaniasis Treatment Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Meglumine Antimoniate
4.2.2 Pentamidine
4.2.3 Hydroxyl Amidine Stilbene
4.2.4 Amphotericin B
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Visceral Leishmaniasis
4.3.2 Cutaneous Leishmaniasis
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Meglumine Antimoniate
5.2.2 Pentamidine
5.2.3 Hydroxyl Amidine Stilbene
5.2.4 Amphotericin B
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Visceral Leishmaniasis
5.3.2 Cutaneous Leishmaniasis
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Meglumine Antimoniate
6.2.2 Pentamidine
6.2.3 Hydroxyl Amidine Stilbene
6.2.4 Amphotericin B
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Visceral Leishmaniasis
6.3.2 Cutaneous Leishmaniasis
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Meglumine Antimoniate
7.2.2 Pentamidine
7.2.3 Hydroxyl Amidine Stilbene
7.2.4 Amphotericin B
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Visceral Leishmaniasis
7.3.2 Cutaneous Leishmaniasis
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Meglumine Antimoniate
8.2.2 Pentamidine
8.2.3 Hydroxyl Amidine Stilbene
8.2.4 Amphotericin B
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Visceral Leishmaniasis
8.3.2 Cutaneous Leishmaniasis
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Meglumine Antimoniate
9.2.2 Pentamidine
9.2.3 Hydroxyl Amidine Stilbene
9.2.4 Amphotericin B
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Visceral Leishmaniasis
9.3.2 Cutaneous Leishmaniasis
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Merck
10.1.2 iCo Therapeutics
10.1.3 AEterna Zentaris
10.1.4 AEterna Zentaris AG
10.1.5 Eurofins Advinus
10.1.6 Pieris Pharmaceuticals
10.1.7 Dafra Pharma
10.2 Leishmaniasis Treatment Sales Date of Major Players (2017-2020e)
10.2.1 Merck
10.2.2 iCo Therapeutics
10.2.3 AEterna Zentaris
10.2.4 AEterna Zentaris AG
10.2.5 Eurofins Advinus
10.2.6 Pieris Pharmaceuticals
10.2.7 Dafra Pharma
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Table
1.Table Leishmaniasis Treatment Product Type Overview
2.Table Leishmaniasis Treatment Product Type Market Share List
3.Table Leishmaniasis Treatment Product Type of Major Players
4.Table Brief Introduction of Merck
5.Table Brief Introduction of iCo Therapeutics
6.Table Brief Introduction of AEterna Zentaris
7.Table Brief Introduction of AEterna Zentaris AG
8.Table Brief Introduction of Eurofins Advinus
9.Table Brief Introduction of Pieris Pharmaceuticals
10.Table Brief Introduction of Dafra Pharma
11.Table Products & Services of Merck
12.Table Products & Services of iCo Therapeutics
13.Table Products & Services of AEterna Zentaris
14.Table Products & Services of AEterna Zentaris AG
15.Table Products & Services of Eurofins Advinus
16.Table Products & Services of Pieris Pharmaceuticals
17.Table Products & Services of Dafra Pharma
18.Table Market Distribution of Major Players
19.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
20.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
21.Table Global Leishmaniasis Treatment Market Forecast (Million USD) by Region 2021f-2026f
22.Table Global Leishmaniasis Treatment Market Forecast (Million USD) Share by Region 2021f-2026f
23.Table Global Leishmaniasis Treatment Market Forecast (Million USD) by Demand 2021f-2026f
24.Table Global Leishmaniasis Treatment Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Leishmaniasis Treatment Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Leishmaniasis Treatment Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Leishmaniasis Treatment Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Leishmaniasis Treatment Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Leishmaniasis Treatment Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Leishmaniasis Treatment Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Leishmaniasis Treatment Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Meglumine Antimoniate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Pentamidine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Hydroxyl Amidine Stilbene Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Amphotericin B Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Visceral Leishmaniasis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Cutaneous Leishmaniasis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Meglumine Antimoniate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Pentamidine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Hydroxyl Amidine Stilbene Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Amphotericin B Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Visceral Leishmaniasis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Cutaneous Leishmaniasis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Meglumine Antimoniate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Pentamidine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Hydroxyl Amidine Stilbene Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Amphotericin B Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Visceral Leishmaniasis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Cutaneous Leishmaniasis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Meglumine Antimoniate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Pentamidine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Hydroxyl Amidine Stilbene Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Amphotericin B Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Visceral Leishmaniasis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Cutaneous Leishmaniasis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Meglumine Antimoniate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Pentamidine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Hydroxyl Amidine Stilbene Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Amphotericin B Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Visceral Leishmaniasis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Cutaneous Leishmaniasis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Meglumine Antimoniate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Pentamidine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Hydroxyl Amidine Stilbene Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Amphotericin B Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Visceral Leishmaniasis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Cutaneous Leishmaniasis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Leishmaniasis Treatment Sales Revenue (Million USD) of Merck 2017-2020e
72.Figure Leishmaniasis Treatment Sales Revenue (Million USD) of iCo Therapeutics 2017-2020e
73.Figure Leishmaniasis Treatment Sal
The Zero Liquid Discharge (ZLD) Brine Treatment Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive la...
Executive Summary
Azoth Analytics has released a research report titled "Global Classic Car Insurance Market (2024 Edition)" which provides a complete analysis of the Global Classic Car Insurance industry in terms of market segmentation By Vehicle Type (Vintage, and Classic), By Ownersh...
Global Fertility Services Market (2024 Edition): Analysis By Gender (Male, Female), Treatment Type (Medicines, Surgical Procedures, and Assisted Conception), Channel (Fertility Clinics, Hospitals, Research Institutes, and Others), Services (IVF, Genetic Testing, and Reproductive Tissue Storage and D...
Executive Summary
Azoth Analytics has released a research report titled "Global Immune Thrombocytopenia Drug Market (2024 Edition)" which provides a complete analysis of the Global Immune Thrombocytopenia Drug industry in terms of market segmentation By Treatment (Intravenous Immunoglob...
The Industrial Flue Gas Treatment Systems & Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competiti...
The Automotive Parts Heat Treatment Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsc...
The Heavy Metal Wastewater Treatment Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lands...
The Stainless Steel Surface Treatment Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
The Semiconductor Anodizing Treatment Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
The Swimming Pool Water Treatment Equipment Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsc...